Raffinose

Star0

DB16839InvestigationalSmall molecule

Raffinose: Overview.

Formula / weight: C₁₈H₃₂O₁₆ · 504.438 g/mol (avg)

Resolves to

Compound

UNIIN5O3QU595MCAS512-69-6ChEMBLCHEMBL603717ChEBI16634KEGGC00492

Clinical / RWD

RxNorm1362905

Structure

InChIKeyMUPFEKGTMRGPLJ-ZQSKZDJDSA-NSMILES[H][C@]1(O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@H](CO[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O

Transporters

P02920lacY

What you can answer from here — as of September 25, 2026

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

14+ReferencesStructured and connected to the statements they support

Which companies are running trials of Raffinose, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account